Related Experiment Videos

Adverse events associated with paediatric use of complementary and alternative medicine: Results of a Canadian

Sunita Vohra1, Jayna Brulotte, Christopher Le

  • 1University of Alberta, Edmonton, Alberta.

Insights

Serious adverse events from pediatric complementary and alternative medicine (CAM) are rare, but delays in diagnosis or treatment are more common. Pediatricians should routinely ask about CAM use to ensure patient safety.

Area of Science:

  • Pediatric Health
  • Integrative Medicine
  • Patient Safety

Background:

  • Complementary and alternative medicine (CAM) use in children is prevalent.
  • Limited data exists on adverse events associated with pediatric CAM use.

Purpose of the Study:

  • To determine the frequency and severity of adverse events linked to pediatric CAM utilization.
  • To assess the impact of CAM on diagnosis and treatment timelines in children.

Main Methods:

  • A national survey was conducted in January 2006.
  • The Canadian Paediatric Surveillance Program distributed surveys to all Canadian pediatricians and subspecialists.
  • Survey questions were developed through literature review and expert consultation.

Main Results:

  • 23% of surveyed pediatricians responded.
  • Pediatricians inquired about CAM use in 38% of cases; patients disclosed use proactively only 22% of the time.
  • 7% of respondents reported adverse events, primarily from natural health products. 18% reported delayed diagnosis or treatment attributed to CAM.

Conclusions:

  • Serious adverse events from pediatric CAM appear infrequent, but delays in diagnosis or treatment are more common.
  • Under-reporting of adverse events is likely due to limited pediatrician-patient discussion about CAM.
  • Active surveillance is necessary to accurately assess pediatric CAM-related adverse events, and routine inquiry by pediatricians is recommended for patient safety.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...